Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03BRB
|
||||
Former ID |
DNC013028
|
||||
Drug Name |
(H-Dmt-Tic-Glu-NH-(CH(2))(5)-CO-Dap(6DMN)-NH(2)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528238] | ||
Structure |
Download2D MOL |
||||
Formula |
C49H58N8O10
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [528238] | |
Mu-type opioid receptor | Target Info | Inhibitor | [528238] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.